Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1996 3
1997 1
1998 1
1999 2
2001 2
2002 1
2003 1
2004 1
2005 2
2006 1
2008 3
2009 3
2010 1
2011 5
2012 4
2013 10
2014 15
2015 13
2016 11
2017 11
2018 15
2019 12
2020 5
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 32972956

101 results
Results by year
Filters applied: . Clear all
Page 1
Are Gadolinium-Enhanced MR Sequences Needed in Simultaneous 18F-FDG-PET/MRI for Tumor Delineation in Head and Neck Cancer?
Pyatigorskaya N, De Laroche R, Bera G, Giron A, Bertolus C, Herve G, Chambenois E, Bergeret S, Dormont D, Amor-Sahli M, Kas A. Pyatigorskaya N, et al. AJNR Am J Neuroradiol. 2020 Oct;41(10):1888-1896. doi: 10.3174/ajnr.A6764. Epub 2020 Sep 24. AJNR Am J Neuroradiol. 2020. PMID: 32972956
Qualitative and quantitative performance of ¹⁸F-FDG-PET/MRI versus ¹⁸F-FDG-PET/CT in patients with head and neck cancer.
Partovi S, Kohan A, Vercher-Conejero JL, Rubbert C, Margevicius S, Schluchter MD, Gaeta C, Faulhaber P, Robbin MR. Partovi S, et al. AJNR Am J Neuroradiol. 2014 Oct;35(10):1970-5. doi: 10.3174/ajnr.A3993. Epub 2014 Jun 12. AJNR Am J Neuroradiol. 2014. PMID: 24924545 Free article.
Progressing Toward a Cohesive Pediatric 18F-FDG PET/MR Protocol: Is Administration of Gadolinium Chelates Necessary?
Klenk C, Gawande R, Tran VT, Leung JT, Chi K, Owen D, Luna-Fineman S, Sakamoto KM, McMillan A, Quon A, Daldrup-Link HE. Klenk C, et al. J Nucl Med. 2016 Jan;57(1):70-7. doi: 10.2967/jnumed.115.161646. Epub 2015 Oct 15. J Nucl Med. 2016. PMID: 26471690 Free PMC article.
Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
Kuhn FP, Hüllner M, Mader CE, Kastrinidis N, Huber GF, von Schulthess GK, Kollias S, Veit-Haibach P. Kuhn FP, et al. J Nucl Med. 2014 Apr;55(4):551-8. doi: 10.2967/jnumed.113.125443. Epub 2014 Feb 3. J Nucl Med. 2014. PMID: 24491410 Free article.
Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI.
Schaarschmidt BM, Heusch P, Buchbender C, Ruhlmann M, Bergmann C, Ruhlmann V, Schlamann M, Antoch G, Forsting M, Wetter A. Schaarschmidt BM, et al. Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):92-102. doi: 10.1007/s00259-015-3145-z. Epub 2015 Aug 6. Eur J Nucl Med Mol Imaging. 2016. PMID: 26243264
Diagnostic accuracy of ultrasound, ¹⁸F-FDG-PET/CT, and fused ¹⁸F-FDG-PET-MR images with DWI for the detection of cervical lymph node metastases of HNSCC.
Heusch P, Sproll C, Buchbender C, Rieser E, Terjung J, Antke C, Boeck I, Macht S, Scherer A, Antoch G, Heusner TA, Handschel J. Heusch P, et al. Clin Oral Investig. 2014 Apr;18(3):969-78. doi: 10.1007/s00784-013-1050-z. Epub 2013 Jul 27. Clin Oral Investig. 2014. PMID: 23892450
More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.
Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Pianou NK, et al. Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003 Free article.
Applying Amide Proton Transfer MR Imaging to Hybrid Brain PET/MR: Concordance with Gadolinium Enhancement and Added Value to [18F]FDG PET.
Sun H, Xin J, Zhou J, Lu Z, Guo Q. Sun H, et al. Mol Imaging Biol. 2018 Jun;20(3):473-481. doi: 10.1007/s11307-017-1136-0. Mol Imaging Biol. 2018. PMID: 29063304 Free PMC article.
Automated computer quantification of breast cancer in small-animal models using PET-guided MR image co-segmentation.
Bagci U, Kramer-Marek G, Mollura DJ. Bagci U, et al. EJNMMI Res. 2013 Jul 5;3(1):49. doi: 10.1186/2191-219X-3-49. EJNMMI Res. 2013. PMID: 23829944 Free PMC article.
Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
Kitagawa Y, Nishizawa S, Sano K, Ogasawara T, Nakamura M, Sadato N, Yoshida M, Yonekura Y. Kitagawa Y, et al. J Nucl Med. 2003 Feb;44(2):198-206. J Nucl Med. 2003. PMID: 12571209 Free article. Clinical Trial.
101 results
Jump to page
Feedback